Sort   by:  
 Page size 
UnknownIron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
Not available
S-EPMC3081953 | biostudies-literature
UnknownCoffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Not available
S-EPMC2783828 | biostudies-literature
UnknownVariants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Not available
S-EPMC2692559 | biostudies-literature
UnknownAn IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.
Not available
S-EPMC3132753 | biostudies-literature
UnknownSafety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study.
Not available
S-EPMC7858210 | biostudies-literature
UnknownPharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation.
Not available
S-EPMC7502355 | biostudies-literature
UnknownExamining Linguistic Differences in Electronic Health Records for Diverse Patients With Diabetes: Natural Language Processing Analysis.
Not available
S-EPMC11137426 | biostudies-literature
UnknownExtended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes.
Not available
S-EPMC3150344 | biostudies-literature
UnknownBI-ALLELIC PATHOGENIC VARIANTS IN NDUFC2 CAUSE EARLY-ONSET LEIGH SYNDROME AND STALLED BIOGENESIS OF COMPLEX I
Not available
S-SCDT-EMM-2020-12619 | biostudies-other
UnknownLong-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.
Not available
S-EPMC7578137 | biostudies-literature
Sort   by:  
 Page size